Thromboxane A Synthase: A New Target for the Treatment of Cardiovascular Diseases

Dinara F Mesitskaya1, Abram L Syrkin1, Marina G Aksenova2

  • 1Sechenov First Moscow State Medical University, Moscow, Russian Federation.

Insights

Atherothrombosis causes significant global mortality. Targeting the thromboxane A2 pathway offers promising new therapeutic strategies for cardiovascular diseases.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacogenomics
  • Thrombosis Research

Background:

  • Atherothrombosis is a leading cause of death worldwide.
  • Novel therapeutic targets for cardiovascular diseases are urgently needed.
  • Pharmacogenomics provides insights into disease mechanisms and treatment.

Purpose of the Study:

  • To review current evidence on the thromboxane A2 pathway in cardiovascular diseases.
  • To explore the potential of targeting the thromboxane A2 - thromboxane A synthase - thromboxane A2 receptor axis.
  • To identify new therapeutic opportunities for atherothrombosis.

Main Methods:

  • Literature review of recent studies.
  • Analysis of pharmacogenomic data.
  • Focus on the thromboxane A2 signaling pathway.

Main Results:

  • The thromboxane A2 pathway is implicated in atherothrombosis pathogenesis.
  • Pharmacogenomic insights highlight this axis as a potential therapeutic target.
  • Systematic research in this area is advancing treatment options.

Conclusions:

  • Targeting the thromboxane A2 axis presents a promising avenue for cardiovascular disease treatment.
  • Further research into this pathway could lead to novel pharmacotherapies.
  • This approach holds potential for managing patients with cardiovascular diseases.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
577
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
966
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
15.6K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
17.3K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
518